http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1832310-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6da7ed4d5a6e834a30e98010d98b8f7b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0573 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-056 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 |
| filingDate | 2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ffa24b2c15356e5306ffb68ea16bc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2beb2e14d4aed39601b475c233bf0472 |
| publicationDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1832310-A2 |
| titleOfInvention | Medical lead with tissue-protecting tip structure |
| abstract | A transvenous cardiac lead (102) comprises a lead body (104) having a distal end portion (108) comprising a tip (130) adapted to be placed in engagement with cardiac tissue. A protective device (136) is carried by the distal end portion (108) of the lead body (104) in operative association with the tip (130), the protective device (136) being deployable following placement of the tip (130) to protect the cardiac tissue engaged by the tip (130). The deployable protective device (136) may be expandable upon implantation to provide a larger surface area or footprint about the lead tip (130) so as to retard or reduce the risk of penetration or perforation of the myocardium by the tip. The protective device (136) may comprise a matrix expandable in response to contact with bodily fluids. |
| priorityDate | 2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.